Contribution: Industrial Research Assistance Program – Contributions to Firms
DeCell Technologies Incorporated
$50,000.00
Automation of Novel Allograft Processing/Packaging Unit for DermGEN™
EF 2018-19 · 2019-01-03
Résumé
DermGEN™ has been developed as a novel decellularized allograft for the wound care market and is poised to commence commercial sales. DeCell Technologies proposal is to automate the decellularization process, using a closed system, dramatically reducing risks of contamination. Full automation of such a system has not been achieved by competing products, and would significantly differentiate DeCell Technologies platform from the competition as well as providing a significant cost advantage.
Ministère
Programme
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (lien de confiance élevée)
Bénéficiaire
Emplacement
Upper Tantallon|Upper Tantallon, Nova Scotia, Canada
Type de bénéficiaire
For-profit organization
Numéro d'entreprise
819980301
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Tel que publié
Agreement End Date
2019-04-19
Agreement Number
918410
Agreement Start Date
2019-01-03
Agreement Title
Automation of Novel Allograft Processing/Packaging Unit for DermGEN™
Agreement Title (French)
Automatisation d'une nouvelle unité de traitement / d’emballage d'allogreffes pour DermGEN™
Agreement Type
Contribution
Agreement Value
$50,000.00
Amendment Number
0
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
DermGEN™ has been developed as a novel decellularized allograft for the wound care market and is poised to commence commercial sales. DeCell Technologies proposal is to automate the decellularization process, using a closed system, dramatically reducing risks of contamination. Full automation of such a system has not been achieved by competing products, and would significantly differentiate DeCell Technologies platform from the competition as well as providing a significant cost advantage.
Description (French)
DermGEN™ a été développé comme une allogreffe déscellularisée innovante pour le marché du soin des plaies et est sur le point d'être commercialisée. La proposition de DeCell Technologies est d'automatiser le processus de déscellularisation, en utilisant un système fermé, réduisant considérablement les risques de contamination. L'automatisation complète d'un tel système n'a pas été réalisée par des produits concurrents et différencierait considérablement la plate-forme DeCell Technologies de la concurrence, tout en offrant un avantage de coût significatif.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
South Shore--St. Margarets
Federal Riding (French)
South Shore--St. Margarets
Federal Riding Number
12009
NAICS Code
541710
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
819980301
Recipient City
Upper Tantallon|Upper Tantallon
Recipient Country
CA
Recipient Legal Name
DeCell Technologies Incorporated
Recipient Postal Code
B3Z 0G2
Recipient Province or Territory
NS
Recipient Type
F
Reference Number
172-2018-2019-Q4-918410
